Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Rules and Regulations 573 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitation or revocation of certain 

notification requirements. The 

provisions of § 721.185 apply to this 

section. 

§ 721.11446 Alkenoic acid, polymer with 

alkanediyl bis substituted alkylene bis 

heteromonocycle, substituted 

carbomonocycle and (alkylalkenyl) 

carbomonocycle, alkali metal salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkenoic acid, polymer 

with alkanediyl bis substituted alkylene 

bis heteromonocycle, substituted 

carbomonocycle and (alkylalkenyl) 

carbomonocycle, alkali metal salt (PMN 

P–19–120) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. (2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) where N=78. 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of Subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitation or revocation of certain 

notification requirements. The 

provisions of § 721.185 apply to this 

section. 

[FR Doc. 2024–30964 Filed 1–3–25; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 372 

[EPA–HQ–OPPT–2024–0044; FRL 9427.2– 

01–OCSPP] 

RIN 2070–AL23 

Implementing Statutory Addition of 

Certain Per- and Polyfluoroalkyl 

Substances (PFAS) to Toxics Release 

Inventory (TRI) Beginning With 

Reporting Year 2025 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Final rule. 

SUMMARY: The Environmental Protection 

Agency (EPA) is updating the list of 

chemicals subject to toxic chemical 

release reporting under the Emergency 

Planning and Community Right-toKnow Act (EPCRA) and the Pollution 

Prevention Act (PPA). Specifically, this 

action updates the regulations to 

identify nine per- and polyfluoroalkyl 

substances (PFAS) that must be reported 

pursuant to the National Defense 

Authorization Act for Fiscal Year 2020 

(FY2020 NDAA) enacted on December 

20, 2019. As this action is being taken 

to conform the regulations to a 

Congressional legislative mandate, 

notice and comment rulemaking is 

unnecessary. 

DATES: This final rule is effective 

February 5, 2025. 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2024–0044, is 

available at https://

www.regulations.gov. Additional 

instructions on visiting the docket, 

along with more information about 

dockets generally, is available at https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

Daniel R. Ruedy, Data Gathering, 

Management and Policy Division 

(7607M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001; telephone 

number: (202) 564–7974; email address: 

ruedy.daniel@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you manufacture, process, 

or otherwise use any of the PFAS listed 

in this rule, including but not limited to 

entities identified with the following 

North American Industry Classification 

System (NAICS) codes. 

• Facilities included in the following 

NAICS manufacturing codes 

(corresponding to Standard Industrial 

Classification (SIC) codes 20 through 

39): 311*, 312*, 313*, 314*, 315*, 316, 

321, 322, 323*, 324, 325*, 326*, 327*, 

331, 332, 333, 334*, 335*, 336, 337*, 

339*, 111998*, 113310, 211130*, 

212323*, 212390*, 488390*, 512230*, 

512250*, 5131*, 516210*, 519290*, 

541713*, 541715* or 811490*. 

*Exceptions and/or limitations exist for 

these NAICS codes. 

• Facilities included in the following 

NAICS codes (corresponding to SIC 

codes other than SIC codes 20 through 

39): 211130* (corresponds to SIC code 

1321, Natural Gas Liquids, and SIC 

2819, Industrial Inorganic Chemicals, 

Not Elsewhere Classified); or 212114, 

212115, 212220, 212230, 212290*; or 

2211*, 221210*, 221330 (limited to 

facilities that combust coal and/or oil 

for the purpose of generating power for 

distribution in commerce) (corresponds 

to SIC codes 4911, 4931, and 4939, 

Electric Utilities); or 424690, 424710 

(corresponds to SIC code 5171, 

Petroleum Bulk Terminals and Plants); 

425120 (limited to facilities previously 

classified in SIC code 5169, Chemicals 

and Allied Products, Not Elsewhere 

Classified); or 562112 (limited to 

facilities primarily engaged in solvent 

recovery services on a contract or fee 

basis (previously classified under SIC 

code 7389, Business Services, NEC)); or 

562211*, 562212*, 562213*, 562219*, 

562920 (limited to facilities regulated 

under the Resource Conservation and 

Recovery Act, subtitle C, 42 U.S.C. 6921 

et seq.) (corresponds to SIC code 4953, 

Refuse Systems). *Exceptions and/or 

limitations exist for these NAICS codes. 

• Federal facilities. 

A more detailed description of the 

types of facilities subject to reporting 

under EPCRA section 313 can be found 

at: https://www.epa.gov/toxics-releaseinventory-tri-program/tri-coveredindustry-sectors. To determine whether 

your facility would be affected by this 

action, you should carefully examine 

the applicability criteria in 40 CFR part 

372, subpart B. If you have questions 

regarding the applicability of this action 

to a particular entity, consult the person 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. What action is the Agency taking? 

EPA is codifying the addition of the 

nine PFAS added to the EPCRA section 

313 list of reportable chemicals (more 

commonly known as the Toxics Release 

Inventory (TRI)) since the last 

conforming rule pursuant to the FY2020 

NDAA ((89 FR 43331; May 17, 2024) 

(FRL–9427.1–01–OCSPP)). 

C. What is the Agency’s authority for 

taking this action? 

This action is issued under authority 

of EPCRA section 313 (42 U.S.C. 11001 

et seq.), PPA section 6607 (42 U.S.C. 

13106), and FY2020 NDAA section 7321 

(Pub. L. 116–92). 

II. Background 

A. What is NDAA Section 7321? 

The FY2020 NDAA was signed into 

law on December 20, 2019. Among other 

provisions, section 7321(c) identifies 

certain regulatory activities that 

automatically add PFAS or classes of 

PFAS to the EPCRA section 313 list of 

reportable chemicals. PFAS or classes of 

PFAS shall be added to the EPCRA 


khammond on DSK9W7S144PROD with RULES
574 Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Rules and Regulations 

section 313 list of reportable chemicals 

beginning January 1 of the calendar year 

after any one of the following dates: 

• Final Toxicity Value. The date on 

which the Administrator finalizes a 

toxicity value for the PFAS or class of 

PFAS; 

• Significant New Use Rule. The date 

on which the Administrator makes a 

covered determination for the PFAS or 

class of PFAS; 

• Addition to Existing Significant 

New Use Rule. The date on which the 

PFAS or class of PFAS is added to a list 

of substances covered by a covered 

determination; 

• Addition as an Active Chemical 

Substance. The date on which the PFAS 

or class of PFAS to which a covered 

determination applies is: 

(1) Added to the list published under 

section 8(b)(1) of the Toxic Substances 

Control Act (TSCA) (15 U.S.C. 2601 et 

seq.) and designated as an active 

chemical substance under TSCA section 

8(b)(5)(A); or 

(2) Designated as an active chemical 

substance under TSCA section 8(b)(5)(B) 

on the list published under TSCA 

section 8(b)(1). 

The FY2020 NDAA defines ‘‘covered 

determination’’ as a determination made 

by rule under TSCA section 5(a)(2) that 

a use of a PFAS or class of PFAS is a 

significant new use (except such a 

determination made in connection with 

a determination described in TSCA 

sections 5(a)(3)(B) or 5(a)(3)(C)). 

Under FY2020 NDAA section 7321(e), 

EPA must review confidential business 

information (CBI) claims before PFAS 

are added to the list pursuant to FY2020 

NDAA sections 7321(b)(1), (c)(1), or 

(d)(3) whose identities are subject to a 

claim of protection from disclosure 

under 5 U.S.C. 552(a), pursuant to 5 

U.S.C. 552(b)(4). Under the FY2020 

NDAA EPA must: 

• Review a claim of protection from 

disclosure; and 

• Require that person to reassert and 

substantiate or re-substantiate that claim 

in accordance with TSCA section 14(f) 

(15 U.S.C. 2613(f)). 

In addition, if EPA determines that 

the chemical identity of a PFAS or class 

of PFAS qualifies for protection from 

disclosure, EPA must include the PFAS 

or class of PFAS on the TRI in a manner 

that does not disclose the protected 

information. 

B. What PFAS have been added to the 

TRI list? 

EPA has reviewed the above-listed 

criteria and found nine chemicals that 

meet the requirements of this part of the 

FY2020 NDAA and have an identity not 

claimed as CBI. 

Chemical name/CASRN * Triggering action Effective 

date 

Ammonium perfluorodecanoate (PFDA NH4) (3108–42–7) ........................................ Final Toxicity Value (Ref. 1) ..................... 1/1/25 

Sodium perfluorodecanoate (PFDA-Na) (3830–45–3) ................................................. Final Toxicity Value (Ref. 1) ..................... 1/1/25 

Perfluoro-3-methoxypropanoic acid (377–73–1) .......................................................... Final Toxicity Value (Ref. 2) ..................... 1/1/25 

6:2 Fluorotelomer sulfonate acid (27619–97–2) .......................................................... Final Toxicity Value (Ref. 3) ..................... 1/1/25 

6:2 Fluorotelomer sulfonate anion (425670–75–3) ...................................................... Final Toxicity Value (Ref. 3) ..................... 1/1/25 

6:2 Fluorotelomer sulfonate potassium salt (59587–38–1) ......................................... Final Toxicity Value (Ref. 3) ..................... 1/1/25 

6:2 Fluorotelomer sulfonate ammonium salt (59587–39–2) ........................................ Final Toxicity Value (Ref. 3) ..................... 1/1/25 

6:2 Fluorotelomer sulfonate sodium salt (27619–94–9) .............................................. Final Toxicity Value (Ref. 3) ..................... 1/1/25 

Acetic acid, [(g-w-perfluoro-C8–10-alkyl)thio] derivs., Bu esters (3030471–22–5) ...... CBI Declassification (Ref. 4) .................... 1/1/25 

* CASRN means Chemical Abstracts Service Registry Number. 

Under FY2020 NDAA section 7321(e), 

EPA must review CBI claims before 

PFAS with identities subject to a claim 

of protection from disclosure under 5 

U.S.C. 552(a) (pursuant to 5 U.S.C. 

552(b)(4)) are added to the list. The 

substance with the CASRN 3030471– 

22–5 met the criteria under FY2020 

NDAA section 7321(c)(1)(A)(iii) but was 

subject to a claim of protection from 

disclosure under 5 U.S.C. 552(b)(4) at 

that time (i.e., when the FY2020 NDAA 

was enacted). This substance’s identity 

was published on the non-confidential 

portion of the TSCA Inventory in 2024; 

therefore, pursuant to FY2020 NDAA 

section 7321(e) the chemical was added 

to the TRI list and is being codified in 

the CFR by this rulemaking. 

As established by the FY2020 NDAA, 

the addition of these PFAS to the 

EPCRA section 313 list of reportable 

chemicals is effective January 1 of the 

calendar year following any of the dates 

identified in FY2020 NDAA section 

7321(c)(1)(A). Accordingly, these nine 

PFAS are reportable beginning with the 

2025 reporting year (i.e., reports due by 

July 1, 2026), and EPA is issuing this 

final rule to amend the EPCRA section 

313 list of reportable chemicals in 40 

CFR 372.65 to include the nine non-CBI 

PFAS added pursuant to the FY2020 

NDAA. 

Note that pursuant to the rule, 

entitled ‘‘Changes to Reporting 

Requirements for Per- and 

Polyfluoroalkyl Substances and to 

Supplier Notifications for Chemicals of 

Special Concern; Community Right-toKnow Toxic Chemical Release 

Reporting; Final Rule’’ (88 FR 74360, 

October 31, 2023 (FRL–8741–04– 

OCSPP)), all PFAS added to TRI 

pursuant to FY2020 NDAA sections 

7321(b) and (c), are designated as 

chemicals of special concern (40 CFR 

372.28), which also applies to the nine 

PFAS identified in this rulemaking. 

Chemicals of special concern are 

excluded from the de minimis 

exemption, may not be reported on a 

Form A (Alternate Threshold 

Certification Statement), and have limits 

related to reporting requirements. For 

more information on the addition of 

PFAS to the list of chemicals of special 

concern, see 40 CFR 372.28. 

III. Good Cause Exception 

Section 553(b)(B) of the 

Administrative Procedure Act (APA), 5 

U.S.C. 553(b)(B), provides that, when an 

agency for good cause finds that public 

notice and comment procedures are 

impracticable, unnecessary, or contrary 

to the public interest, the agency may 

issue a rule without providing notice 

and an opportunity for public comment. 

EPA has determined that there is good 

cause for making this rule final without 

prior proposal and opportunity for 

comment because such notice and 

opportunity for comment is 

unnecessary. This action is being taken 

to comply with a mandate in an Act of 

Congress, in which Congress identified 

actions that automatically add these 

chemicals to the TRI. Thus, EPA has no 

discretion as to the outcome of this rule, 

which aligns the regulations with the 

self-effectuating changes provided by 

the FY2020 NDAA. 

IV. References 

The following is a listing of the 

documents that are specifically 

referenced in this document. The docket 

includes these documents and other 


khammond on DSK9W7S144PROD with RULES
Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Rules and Regulations 575 

information considered by EPA, 

including documents that are referenced 

within the documents that are included 

in the docket, even if the referenced 

document is not itself physically located 

in the docket. For assistance in locating 

these other documents, please consult 

the person listed under FOR FURTHER

INFORMATION CONTACT. 

1. EPA. IRIS Toxicological Review of 

Perfluorodecanoic Acid (PFDA) and 

Related Salts. U.S. Environmental 

Protection Agency, Washington, DC, 

EPA/635/R–24/172Fa. 2024. 

2. EPA. EPA Transcriptomic Assessment 

Product (ETAP) for Perfluoro-3- 

Methoxypropanoic Acid. U.S. 

Environmental Protection Agency, 

Washington, DC, EPA/600/X–24/066. 

2024. 

3. EPA. ORD Human Health Toxicity Value 

for 6:2 Fluorotelomer Sulfonic Acid. U.S. 

Environmental Protection Agency, 

Washington, DC, EPA/600/R–24/315. 

2024. 

4. EPA. Non-CBI TSCA Inventory, May 2024. 

V. Statutory and Executive Order 

Reviews 

Additional information about these 

statutes and Executive orders can be 

found at https://www.epa.gov/lawsregulations/laws-and-executive-orders. 

A. Executive Order 12866: Regulatory 

Planning and Review and 14094: 

Modernizing Regulatory Review 

This action is not a significant 

regulatory action as defined in 

Executive Order 12866 (58 FR 51735, 

October 4, 1993), as amended by 

Executive Order 14094 (88 FR 21879, 

April 11, 2023), and was therefore not 

subject to a requirement for Executive 

Order 12866 review. 

B. Paperwork Reduction Act (PRA) 

This action does not impose any new 

information collection burden under the 

PRA, 44 U.S.C. 3501 et. seq. Burden is 

defined in 5 CFR 1320.3(b). The Office 

of Management and Budget (OMB) has 

previously approved the information 

collection activities contained in the 

existing regulations and assigned OMB 

control numbers 2070–0212 and 2050– 

0078. 

Currently, the facilities subject to the 

reporting requirements under EPCRA 

section 313 and PPA section 6607 must 

use EPA Toxic Chemicals Release 

Inventory Form R (EPA Form 9350–1). 

The nine newly added PFAS are subject 

to the same reporting requirements as 

other chemicals of special concern and 

are excluded from certain burdenreduction reporting options (i.e., the de 

minimis exemption and the option to 

use Form A, range reporting). The Form 

R must be completed if a facility 

manufactures, processes, or otherwise 

uses any listed chemical above 

threshold quantities and meets certain 

other criteria. 

Respondents may designate the 

specific chemical identity of a substance 

as a trade secret pursuant to EPCRA 

section 322 (42 U.S.C. 11042) and 40 

CFR part 350. OMB has approved the 

reporting and recordkeeping 

requirements related to Form R, 

supplier notification, and petitions 

under OMB Control No. 2070–0212 

(EPA Information Collection Request 

(ICR) No. 2613.04) and those related to 

trade secret designations under OMB 

Control No. 2050–0078 (EPA ICR No. 

1428.12). 

An agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid OMB 

control number. The OMB control 

numbers relevant to EPA’s regulations 

in 40 CFR are listed in 40 CFR part 9 

and displayed on the information 

collection instruments (e.g., forms, 

instructions). 

C. Regulatory Flexibility Act (RFA) 

This action is not subject to the RFA, 

5 U.S.C. 601 et seq. The RFA applies 

only to rules subject to notice and 

comment rulemaking requirements 

under the APA, 5 U.S.C. 553, or any 

other statute. As discussed in Unit III., 

this rule is not subject to notice and 

comment requirements because the 

Agency has invoked the APA ‘‘good 

cause’’ exception under 5 U.S.C. 553(b). 

D. Unfunded Mandates Reform Act 

(UMRA) 

This action does not contain any 

unfunded mandate of $100 million or 

more as described in UMRA, 2 U.S.C. 

1531–1538, and does not significantly or 

uniquely affect small governments. The 

action imposes no enforceable duty on 

any State, local, or Tribal governments 

or the private sector. 

E. Executive Order 13132: Federalism 

This action does not have federalism 

implications, as specified in Executive 

Order 13132 (64 FR 43255, August 10, 

1999), because it will not have 

substantial direct effects on states, on 

the relationship between the National 

Government and the States, or on the 

distribution of power and 

responsibilities among the various 

levels of government. 

F. Executive Order 13175: Consultation 

and Coordination With Indian Tribal 

Governments 

This action does not have Tribal 

implications, as specified in Executive 

Order 13175 (65 FR 67249, November 9, 

2000) because it will not have 

substantial direct effects on Tribal 

governments, on the relationship 

between the Federal government and 

the Indian Tribes, or on the distribution 

of power and responsibilities between 

the Federal Government and Indian 

Tribes. It does not have substantial 

direct effects on Tribal governments 

because EPA does not anticipate that 

reporting of the PFAS added to the TRI 

list in this action will be conducted by 

Tribes, so this rulemaking is not 

expected to impose substantial direct 

compliance costs on Tribal 

governments. 

G. Executive Order 13045: Protection of 

Children From Environmental Health 

Risks and Safety Risks 

This action is not subject to Executive 

Order 13045 (62 FR 19885, April 23, 

1997) because it does not concern an 

environmental health or safety risk. 

Since this action does not concern 

human health, EPA’s 2021 Policy on 

Children’s Health also does not apply. 

Although this action does not concern 

an environmental health or safety risk, 

this reporting rule will aid in collecting 

information regarding PFAS. This rule 

will be of use in identifying releases of 

PFAS to which children may be 

exposed. EPA believes that the 

information obtained as a result of this 

action could also be used by the public, 

government agencies and others to 

identify potential problems, set 

priorities, and take appropriate steps to 

reduce any potential human health or 

environmental risks related to PFAS, 

including those that may 

disproportionately affect children. 

H. Executive Order 13211: Actions 

Concerning Regulations That 

Significantly Affect Energy Supply, 

Distribution, or Use 

This action is not a significant energy 

action as defined in Executive Order 

13211 (66 FR 28355, May 22, 2001), 

because it is not likely to have a 

significant adverse effect on the supply, 

distribution or use of energy. 

I. National Technology Transfer and 

Advancement Act (NTTAA) 

This rulemaking does not involve 

technical standards. As such, NTTAA 

section 12(d), 15 U.S.C. 272, does not 

apply to this action. 


khammond on DSK9W7S144PROD with RULES
576 Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Rules and Regulations 

J. Executive Order 12898: Federal 

Actions To Address Environmental 

Justice in Minority Populations and 

Low-Income Populations and Executive 

Order 14096: Revitalizing Our Nation’s 

Commitment to Environmental Justice 

for All 

Executive Order 12898 (59 FR 7629, 

February 16, 1994) directs Federal 

agencies, to the greatest extent 

practicable and permitted by law, to 

make environmental justice a part of 

their mission by identifying and 

addressing, as appropriate, 

disproportionately high and adverse 

human health or environmental effects 

of their programs, policies, and 

activities on minority populations 

(people of color) and low-income 

populations. 

EPA believes that this type of action 

does not concern human health or 

environmental conditions and therefore 

cannot be evaluated with respect to 

potentially disproportionate and 

adverse effects on communities with 

environmental justice concerns. This 

action involves additions to reporting 

requirements that will not affect the 

level of protection provided to human 

health or the environment. 

Although this action does not concern 

human health or environmental 

conditions, EPA may identify and 

address environmental justice concerns 

through information collected under 

TRI. The information obtained as a 

result of this rulemaking will lead to a 

better understanding of PFAS releases, 

which can help inform and tailor future 

EPA actions regarding PFAS. For 

example, EPA may identify and address 

environmental justice concerns as a 

result of the new PFAS information 

collected under this rule. The action 

will also better inform communities 

living near facilities that report to TRI, 

by providing them with information 

about PFAS releases and waste 

management practices occurring in their 

communities. Overall, EPA believes that 

the information obtained as a result of 

this action could be used by the public 

(including people of color, low-income 

populations and/or indigenous peoples) 

to inform their behavior as it relates to 

potential exposure to PFAS and by 

government agencies and others to 

identify potential problems, set 

priorities, and take appropriate steps to 

reduce any potential human health or 

environmental risks from PFAS. 

K. Congressional Review Act (CRA) 

This action is subject to the CRA, 5 

U.S.C. 801 et seq., and EPA will submit 

a rule report to each House of the 

Congress and to the Comptroller General 

of the United States. This action is not 

a ‘‘major rule’’ as defined by 5 U.S.C. 

804(2). 

List of Subjects in 40 CFR Part 372 

Environmental protection, 

Community right-to-know, Reporting 

and recordkeeping requirements, Toxic 

chemicals. 

Dated: December 26, 2024. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

Therefore, for the reasons stated in the 

preamble, EPA is amending 40 CFR part 

372 as follows: 

PART 372—TOXIC CHEMICAL 

RELEASE REPORTING: COMMUNITY 

RIGHT-TO-KNOW 

■ 1. The authority citation for part 372 

continues to read as follows: 

Authority: 42 U.S.C. 11023 and 11048. 

■ 2. Amend § 372.65 by: 

■ a. In paragraph (d) in table 4, adding 

in alphabetical order entries for ‘‘Acetic 

acid, [(g- w-perfluoro-C8–10-alkyl)thio] 

derivs., Bu esters’’; ‘‘Ammonium 

perfluorodecanoate (PFDA NH4)’’; ‘‘6:2 

Fluorotelomer sulfonate acid’’; ‘‘6:2 

Fluorotelomer sulfonate ammonium 

salt’’; ‘‘6:2 Fluorotelomer sulfonate 

anion’’; ‘‘6:2 Fluorotelomer sulfonate 

potassium salt’’; ‘‘6:2 Fluorotelomer 

sulfonate sodium salt’’; ‘‘Perfluoro-3- 

methoxypropanoic acid’’; ‘‘Sodium 

perfluorodecanoate (PFDA-Na)’’. 

■ b. In paragraph (e) in table 5, adding 

in numerical order entries for ‘‘377–73– 

1’’; ‘‘3108–42–7’’; ‘‘3830–45–3’’; 

‘‘27619–94–9’’; ‘‘27619–97–2’’; ‘‘59587– 

38–1’’; ‘‘59587–39–2’’; ‘‘425670–75–3’’; 

‘‘3030471–22–5’’. 

The additions read as follows: 

§ 372.65 Chemicals and chemical 

categories to which this part applies. 

* * * * * 

(d) * * * 

TABLE 4 TO PARAGRAPH (d) 

Chemical name CASRN 1 Effective date 

*******

Acetic acid, [(g-w-perfluoro-C8–10-alkyl)thio] derivs., Bu esters ............................................................................. 3030471–22–5 1/1/25 

*******

Ammonium perfluorodecanoate (PFDA NH4) ......................................................................................................... 3108–42–7 1/1/25 

*******

6:2 Fluorotelomer sulfonate acid ............................................................................................................................. 27619–97–2 1/1/25 

6:2 Fluorotelomer sulfonate ammonium salt ........................................................................................................... 59587–39–2 1/1/25 

6:2 Fluorotelomer sulfonate anion ........................................................................................................................... 425670–75–3 1/1/25 

6:2 Fluorotelomer sulfonate potassium salt ............................................................................................................. 59587–38–1 1/1/25 

6:2 Fluorotelomer sulfonate sodium salt ................................................................................................................. 27619–94–9 1/1/25 

*******

Perfluoro-3-methoxypropanoic acid ......................................................................................................................... 377–73–1 1/1/25 

*******

.

Sodium perfluorodecanoate (PFDA-Na) .................................................................................................................. 3830–45–3 1/1/25 

*******

1 CASRN means Chemical Abstracts Service Registry Number. 


khammond on DSK9W7S144PROD with RULES
Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Rules and Regulations 577 

(e) * * * 

TABLE 5 TO PARAGRAPH (e) 

CASRN 1 Chemical name Effective 

date 

*******

377–73–1 ..... Perfluoro-3-methoxypropanoic acid .......................................................................................................................... 1/1/25 

* * * * * * * 

3108–42–7 ... Ammonium perfluorodecanoate (PFDA NH4) .......................................................................................................... 1/1/25 

* * * * * * * 

3830–45–3 ... Sodium perfluorodecanoate (PFDA-Na) ................................................................................................................... 1/1/25 

* * * * * * * 

27619–94–9 6:2 Fluorotelomer sulfonate sodium salt .................................................................................................................. 1/1/25 

* * * * * * * 

27619–97–2 6:2 Fluorotelomer sulfonate acid .............................................................................................................................. 1/1/25 

* * * * * * * 

59587–38–1 6:2 Fluorotelomer sulfonate potassium salt .............................................................................................................. 1/1/25 

* * * * * * * 

59587–39–2 6:2 Fluorotelomer sulfonate ammonium salt ............................................................................................................ 1/1/25 

* * * * * * * 

425670–75–3 6:2 Fluorotelomer sulfonate anion ............................................................................................................................ 1/1/25 

* * * * * * * 

3030471–22– 

5.

Acetic acid, [(g-w-perfluoro-C8–10-alkyl)thio] derivs., Bu esters .............................................................................. 1/1/25 

*******

1 CASRN means Chemical Abstracts Service Registry Number. 

[FR Doc. 2024–31464 Filed 1–3–25; 8:45 am] 

BILLING CODE 6560–50–P 


khammond on DSK9W7S144PROD with RULES